Estimating the accuracy of screening mammography: A meta-analysis

American Journal of Preventive Medicine

Volumn 14, Issue 2, 1998, Pages 143-153

  Mushlin, Alvin I ^a,b   Kouides, Ruth W ^a   Shapiro, David E ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HEALTH CARE PLANNING; HUMAN; MAMMOGRAPHY; META ANALYSIS; PHYSICIAN; RECEIVER OPERATING CHARACTERISTIC; REVIEW; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY;

EID: 0032004716     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(97)00019-6     Document Type: Review

References (78)

1. 1. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993;85:1644-56.
2. 2. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273(2):149-54.
3. 3. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women [published errata appear in Online J Curr Clin Trials 1993 Mar 5; Doc No 34: and 1994 Mar 31; Doc No. 121]. Online J Curr Clin Trials 1993; Doc No. 32.
4. 4. Hurley SF, Kaldor JM. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 1992; 14:101-30.
5. 5. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials [published erratum appears in Lancet 1993 Nov 27;342(8883):1372]. Lancet 1993;341:973-8.
6. 6. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993;270:2444-50.
7. 7. Irwig L, Tosteson AN, Gatsonis C, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994;120:667-76.
8. 8. Shapiro DE. Issues in combining independent estimates of sensitivity and specificity of a diagnostic test. Acad Radiol 1995;(2):S37-S47.
9. 9. Gad A, Thomas BA, Moskowitz M. Screening for breast cancer in Europe: achievements, problems, and future. Recent Results Cancer Res 1984;90:179-94.
10. 10. Tabar L, Dean PB. The control of breast cancer through mammography screening: what is the evidence? Radiol Clin North Am 1987;25:993-1005.
11. 11. DiGuiseppi C., A.I. Mushlin. 1993; Letter from U.S. Preventive Services Task Force.
12. 12. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-country program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
13. 13. Miller AB. Canadian National Breast Screening Study: public health implications. Can J Public Health 1993;84: 14-6.
14. 14. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996; 276(1):33-38.
15. 15. Midgette AS, Stukel TA, Littenberg B. A meta-analytic method for summarizing diagnostic test performances: receiver-operating-characteristic-summary point estimates. Med Decis Making 1993;13:253-7.
16. 16. Kardaun JW, Kardaun OJ. Comparative diagnostic performance of three radiological procedures for the detection of lumbar disk herniation. Methods Inf Med 1990;29(1): 12-22.
17. 17. Eddy DM, Hasselblad V, McGivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA 1988;259(10):1512-9.
18. 18. Mushlin AI, Fintor L. Is screening for breast cancer cost-effective? Cancer 1992;69(suppl 7):1957-62.
19. 19. Kaufman Z, Garstin WI, Haves R, Michell MJ, Baum M. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 1991;43: 389-92.
20. 20. Cyriak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. AJR 1993;161:1177-83.
21. 21. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
22. 22. Laya MB, Larson EB, Taplin SH, White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996;88(10):643-9.
23. 23. Chalmers I, Dickersin K, Chalmers TC. Getting to grips with Archie Cochrane's agenda. BMJ 1992;305:786-8.
24. 24. Beam CA, Layde PM, Sullivan DC. Variability in the interpretation of screening mammograms by US radiologists: findings from a national sample. Arch Intern Med 1996;156(2):209-13.
25. 25. Lynde JL. Low-cost screening mammography: results of 21,141 consecutive examinations in a community program. South Med J 1993;86:338-43.
26. 26. Robertson CL. A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 1993;187:75-9.
27. 27. Bird RE. Low-cost screening mammography: report on finances and review of 21,716 consecutive cases. Radiology 1989;171:87-90.
28. 28. Sienko DG, Hahn RA, Mills EM, et al. Mammography use and outcomes in a community. The Greater Lansing Area Mammography Study. Cancer 1993;71:1801-9.
29. 29. Burhenne HJ, Burhenne LW, Goldberg F, et al. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. AJR:1994; 162(5):1067-72.
30. 30. Linver MN, Paster SB, Rosenberg RD, Key CR, Stidley CA, King WV. Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases. Radiology 1992;184:39-43.
31. 31. Dodd GD. Mammography quality assurance programs. Cancer 1994;74:239-43.
32. 32. Paquelet JR. Medicare, mammography, and the Mammography Quality Standards Act of 1992. Radiology 1994; 190:47A-9A.
33. 33. Conway BJ, Suleiman OH, Rueter FG, Antonsen RG, Slayton RJ. National survey of mammographic facilities in 1985, 1988, and 1992. Radiology 1994;191:323-30.
34. 34. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratios for modern screening mammography: risk of breast cancer based on age and mammographic interpretation. JAMA 1996;276(1):39-43.
35. 35. Holmberg LH, Tabar L, Adami HO, Bergstrom R. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986;2:27-30.
36. 36. Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography: randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
37. 37. Tabar L, Fagerberg CJ, Duffy SW, Day NE. The Swedish two-county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989;43:107-14.
38. 38. Tabar L, Fagerberg CJG, South MC, et al. The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumour characteristics. In: Miller AB, Chamberlain J, Day NE, eds. Cancer screening. Cambridge: Cambridge University Press; 1991.
39. 39. Andersson I, Janzon L, Sigfusson BF. Mammographic breast cancer screening: a randomized trial in Malmo, Sweden. Maturitas 1985;7(1):21-9.
40. 40. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988;297(6654): 943-8.
41. 41. Janzon L, Andersson I, Miller, Chamberlain J, Day NE, eds. The Malmo mammographic screening trial. In: Cancer Screening. Cambridge: Cambridge University Press; 1991.
42. 42. von Rosen A, Frisell J, Glas U, et al. Non-palpable invasive breast carcinomas from the Stockholm screening project. Acta Oncol 1989;28:1-4.
43. 43. Frisell J, Eklund G, Hellstrom L, Somell A. Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat 1987;9:219-25.
44. 44. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm: design, first-round results and comparisons. Breast Cancer Res Treat 1986;8:45-54.
45. 45. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991;18:49-56.
46. 46. Lidbrink EK, Tornberg SA, Azavedo EM, et al. The general mammography screening program in Stockholm: organisation and first-round results. Acta Oncol 1994; 33(4):353-8.
47. 47. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years [published erratum appears in Can Med Assoc J 1993 Mar 1;148(5): 718]. Can Med Assoc J 1992;147:1477-88.
48. 48. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published erratum appears in Can Med Assoc J 1993 Mar 1;148(5): 718]. Can Med Assoc J 1992;147(10):1459-76.
49. 49. Baines CJ, Miller AB, Kopans DB, et al. Canadian National Breast Screening Study: assessment of technical quality by external review. AJR 1990;155:743-7; discussion 748.
50. 50. Baines CJ, Miller AB, Bassett AA. Physical examination: its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 1989;63:1816-22.
51. 51. Baines CJ, McFarlane DV, Wall C. Audit procedures in the National Breast Screening Study: mammography interpretation [published erratum appears in J Can Assoc Radiol 1987 Mar;38(1):59]. Ann Epidemiol 1986;37:256-60.
52. 52. Baines CJ, McFarlane DV, Miller AB. Sensitivity and specificity of first screen mammography in 15 NBSS centres. J Can Assoc Radiol 1988;39:273-6.
53. 53. Marshall G. A comparative study of re-attenders and non-re-attenders for second triennial National Breast Screening Programme appointments. J Public Health Med 1994;16(1):79-86.
54. 54. UK Trial of Early Detection of Breast Cancer Group. Toronto: Hans Huber; 1988; Progress Report of the UK Trial of Early Detection of Breast Cancer, pp. 45-9.
55. 55. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr 1985;67:65-74.
56. 56. Shapiro S, Venet W, Strax P, et al. Abeloff MD, Boyer SH, Green GM, et al., eds. Periodic screening for breast cancer. Baltimore: The Johns Hopkins University Press, 1995, pp. 1-57.
57. 57. Anderson TJ, Alexander F, Chetty U, et al. Comparative pathology of prevalent and incident cancers detected by breast screening. Lancet 1986;519-22.
58. 58. Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-6.
59. 59. Roberts MM, Alexander FE, Anderson TJ, et al. The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer 1984;50:1-6.
60. 60. Alexander FE, Roberts MM, Huggins A, Muir BB. Use of risk factors to allocate schedules for breast cancer screening. J Epidemiol Community Health 1988;42:193-9.
61. 61. Alexander FE, Anderson TJ, Donnan PT, Prescott RJ. Edinburgh trial of screening for breast cancer. Lancet 1990;335:968-9.
62. 62. Alexander FE, Anderson TJ, Donnan PT, Prescott RJ. Edinburgh trial of screening for breast cancer. Lancet 1990;335:1290-1.
63. 63. Peeters PH, Verbeek AL, Hendriks JH, van Bon MJ. Screening for breast cancer in Nijmegen: report of 6 screening rounds. 1975-1986. Int J Cancer 1989;43:226-30.
64. 64. de Waard F, Collette HJ, Rombach JJ, Baanders-van Halewinjn EA, Honing C. The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis 1984;37:1-44.
65. 65. Collette HJ, Day NE, Rombach JJ, de Waard F. Evaluation of screening for breast cancer in a non-randomised study (The DOM Project) by means of a case-control study. Lancet 1984;1:1224-6.
66. 66. Collette H, Rombach JJ, de Waard F, et al. Screening for breast cancer. Toronto: Hans Huber; 1988;An Update of the DOM Project for the Early Detection of Breast Cancer, pp. 17-27.
67. 67. Palli D, del Turco MR, Buiatti E, et al. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986;38(4):501-4.
68. 68. Ciatto S, Cecchini S, del Turco MR, Grazzini G, Iossa A, Bartoli D. Referral policy and positive predictive value of call for surgical biopsy in the Florence breast cancer screening program. J Clin Epidemiol 1990;43(5):419-23.
69. 69. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratios for modern screening mammography. JAMA 1996;276(1):39-43.
70. 70. Baker LH. Breast Cancer Detection Demonstration Project: Five-year summary report. CA 1982;32(4):195-225.
71. 71. Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA. Survival experience in the Breast Cancer Detection Demonstration Project. CA 1987;37(5):258-90.
72. 72. Martin JE, Moskowitz M, Milbrath JR. Breast cancer missed by mammography. J Chronic Dis 1979;132:737-9.
73. 73. Codd MB, Laird OM, Dowling M, et al. Screening for breast cancer in Ireland: the Eccles Breast Screening Programme. Eur J Cancer Prev 1994;3(suppl 1):21-8.
74. 74. Garas I, Pateras H, Triandafilou D, et al. Breast cancer screening in southern Greece. European J Cancer Prev 1994;3(suppl 1):35-9.
75. 75. Ascunce N, del Moral A, Murillo A, et al. Early detection programme for breast cancer in Navarra, Spain. European J Cancer Prev 1994;3(suppl 1):41-8.
76. 76. Alves JG, Cruz DB, Rodrigues VL, Goncalves ML, Fernandes E. Breast cancer screening in the central region of Portugal. Eur J Cancer Prev 1994;3(suppl 1):49-53.
77. 77. Renaud R, Gairard B, Schaffer P, et al. Europe against cancer: breast cancer screening programme in France: The ADEMAS programme in Bas-Rhin. Eur J Cancer Prev 1994;3(suppl 1):13-9.
78. 78. Van Oyen H, Verellen W. Breast cancer screening in the Flemish region, Belgium. Eur J Cancer Prev 1994;3(suppl 1):7-12.